Literature DB >> 25523784

Draft Genome Sequence of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii Strain ATCC MYA-796.

T M Batista1, E T A Marques2, G R Franco3, B Douradinha4.   

Abstract

Saccharomyces boulardii is the only yeast approved as a probiotic for human consumption. Here, we report the draft genome sequence of the strain ATCC MYA-796, derived from the French Ultra Levure probiotic drug. The genome has a size of 11.6 Mb with 5,305 putative open reading frames predicted.
Copyright © 2014 Batista et al.

Entities:  

Year:  2014        PMID: 25523784      PMCID: PMC4271174          DOI: 10.1128/genomeA.01345-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Isolated by the French scientist Henri Boulard in 1920 during a cholera outbreak, the yeast Saccharomyces cerevisiae var. boulardii is still the only eukaryotic microorganism used as a probiotic in human health for the treatment of gastrointestinal disorders (1). This probiotic yeast is used worldwide and has been tested for clinical efficacy against several diseases, including traveler’s diarrhea, antibiotic-associated diarrhea (AAD), acute adult diarrhea, HIV-related diarrhea, Helicobacter pylori diseases, Clostridium difficile and Salmonella typhi infections, and Crohn’s disease, among others (2). Recently, a work was published describing the genome of an S. boulardii strain commercialized in India (3). Here, we report the draft genome sequence of S. cerevisiae var. boulardii strain ATCC MYA-796, derived from the French Ultra Levure probiotic drug. The genomic DNA was sequenced using Illumina HiSeq by Axeq Technologies (http://www.axeq.com). A total of 48.3 million paired-end reads of 101 bp with an estimated 403× coverage were produced. Different k-mer values were tested to obtain the ideal value (k 61). The de novo assembly was performed using SOAPdenovo version 2.04 (4) with parameters -R -u -F -M 2. The contigs were scaffolded using SSPACE (5) and ordered by CONTIGuator (6) using the S. cerevisiae S288c genome as a reference; gaps were closed with GapCloser (4). The resulting assembly has 193 contigs (>400 bp) with a total length of 11,405,855 bp (the largest contig having a length of 459,679 bp), an N50 of 203 kb (in 19 contigs), and a G+C content of 38.1% and 100% of completeness, as estimated by mapping the orthologous genes (KOG databases) using CEGMA software (7). Genome annotation performed by MAKER2 (8) revealed 5,305 putative open reading frames (ORFs). An automatic annotation using the BLASTp algorithm (9) revealed 5,321 ORFs with significant similarity (E-value cutoff ≤10−3) to sequences deposited in the non-redundant (nr) protein database from NCBI. Using the tRNAscan-SE version 1.3 software (9), we found 273 tRNA genes scattered across the contigs. The draft sequence of the yeast S. cerevisiae var. boulardii strain ATCC MYA-796 complements the genetic information of this probiotic yeast already deposited in GenBank.

Nucleotide sequence accession numbers.

Data related to the whole-genome shotgun project of S. cerevisiae var. boulardii ATCC MYA-796 has been deposited at DDBJ/EMBL/GenBank under the accession number JRHY00000000. The version herein described is under accession number JRHY01000000.
  9 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Scaffolding pre-assembled contigs using SSPACE.

Authors:  Marten Boetzer; Christiaan V Henkel; Hans J Jansen; Derek Butler; Walter Pirovano
Journal:  Bioinformatics       Date:  2010-12-12       Impact factor: 6.937

3.  CEGMA: a pipeline to accurately annotate core genes in eukaryotic genomes.

Authors:  Genis Parra; Keith Bradnam; Ian Korf
Journal:  Bioinformatics       Date:  2007-03-01       Impact factor: 6.937

4.  Review article: yeast as probiotics -- Saccharomyces boulardii.

Authors:  D Czerucka; T Piche; P Rampal
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

5.  BLAST+: architecture and applications.

Authors:  Christiam Camacho; George Coulouris; Vahram Avagyan; Ning Ma; Jason Papadopoulos; Kevin Bealer; Thomas L Madden
Journal:  BMC Bioinformatics       Date:  2009-12-15       Impact factor: 3.169

6.  CONTIGuator: a bacterial genomes finishing tool for structural insights on draft genomes.

Authors:  Marco Galardini; Emanuele G Biondi; Marco Bazzicalupo; Alessio Mengoni
Journal:  Source Code Biol Med       Date:  2011-06-21

7.  MAKER2: an annotation pipeline and genome-database management tool for second-generation genome projects.

Authors:  Carson Holt; Mark Yandell
Journal:  BMC Bioinformatics       Date:  2011-12-22       Impact factor: 3.307

8.  SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler.

Authors:  Ruibang Luo; Binghang Liu; Yinlong Xie; Zhenyu Li; Weihua Huang; Jianying Yuan; Guangzhu He; Yanxiang Chen; Qi Pan; Yunjie Liu; Jingbo Tang; Gengxiong Wu; Hao Zhang; Yujian Shi; Yong Liu; Chang Yu; Bo Wang; Yao Lu; Changlei Han; David W Cheung; Siu-Ming Yiu; Shaoliang Peng; Zhu Xiaoqian; Guangming Liu; Xiangke Liao; Yingrui Li; Huanming Yang; Jian Wang; Tak-Wah Lam; Jun Wang
Journal:  Gigascience       Date:  2012-12-27       Impact factor: 6.524

9.  Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii.

Authors:  Indu Khatri; Akil Akhtar; Kamaldeep Kaur; Rajul Tomar; Gandham Satyanarayana Prasad; Thirumalai Nallan Chakravarthy Ramya; Srikrishna Subramanian
Journal:  Gut Pathog       Date:  2013-10-22       Impact factor: 4.181

  9 in total
  5 in total

1.  A Mutation in PGM2 Causing Inefficient Galactose Metabolism in the Probiotic Yeast Saccharomyces boulardii.

Authors:  Jing-Jing Liu; Guo-Chang Zhang; In Iok Kong; Eun Ju Yun; Jia-Qi Zheng; Dae-Hyuk Kweon; Yong-Su Jin
Journal:  Appl Environ Microbiol       Date:  2018-05-01       Impact factor: 4.792

Review 2.  Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health.

Authors:  Rameesha Abid; Hassan Waseem; Jafar Ali; Shakira Ghazanfar; Ghulam Muhammad Ali; Abdelbaset Mohamed Elasbali; Salem Hussain Alharethi
Journal:  J Fungi (Basel)       Date:  2022-04-24

3.  Different specificities of two aldehyde dehydrogenases from Saccharomyces cerevisiae var. boulardii.

Authors:  Suprama Datta; Uday S Annapure; David J Timson
Journal:  Biosci Rep       Date:  2017-03-02       Impact factor: 3.840

4.  Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii.

Authors:  Ran Li; Xing Wan; Timo M Takala; Per E J Saris
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

5.  Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature.

Authors:  Serkan Atıcı; Ahmet Soysal; Kıvılcım Karadeniz Cerit; Şerife Yılmaz; Burak Aksu; Gürsu Kıyan; Mustafa Bakır
Journal:  Med Mycol Case Rep       Date:  2017-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.